TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.
Banerjee R, Russo N, Liu M, Basrur V, Bellile E, Palanisamy N, Scanlon CS, van Tubergen E, Inglehart RC, Metwally T, Mani RS, Yocum A, Nyati MK, Castilho RM, Varambally S, Chinnaiyan AM, D'Silva NJ.
Banerjee R, et al. Among authors: scanlon cs.
Nat Commun. 2014 Jul 31;5:4527. doi: 10.1038/ncomms5527.
Nat Commun. 2014.
PMID: 25078033
Free PMC article.